Skip to main content
. 2014 Dec 21;27(2):258–268. doi: 10.1111/nmo.12484

Figure 2.

Figure 2

Mean (SD) number of daily occurrences of: (A) heartburn; (B) regurgitation; and (C) heartburn and/or regurgitation, during the run-in and at week 4 as reported in e-diaries. n = 28–31. Note that differences in the changes from baseline to week 4 between placebo and revexepride groups were not significant. SD, standard deviation; t.i.d., three times daily.